Comparative Pharmacology
Head-to-head clinical analysis: MULTIHANCE MULTIPACK versus OPTIMARK.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MULTIHANCE MULTIPACK versus OPTIMARK.
MULTIHANCE MULTIPACK vs OPTIMARK
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Gadobenate dimeglumine is a paramagnetic contrast agent that enhances magnetic resonance imaging by increasing the relaxation rate of water protons in tissues where it accumulates. The gadolinium ion (Gd3+) shortens T1 and T2 relaxation times, leading to increased signal intensity on T1-weighted images.
Gadolinium-based MRI contrast agent that increases signal intensity by shortening T1 relaxation time in tissues where it accumulates.
0.1 mmol/kg body weight (0.2 mL/kg) intravenous bolus injection; maximum single dose 0.3 mmol/kg (0.6 mL/kg)
0.1 mmol/kg (0.2 mL/kg) intravenously as a single bolus injection; not to exceed 20 mL per dose.
None Documented
None Documented
Terminal elimination half-life: 1.5–2.2 hours in patients with normal renal function; prolonged (up to 30 hours) in severe renal impairment (eGFR <30 mL/min/1.73m²)
Terminal elimination half-life is approximately 1.5–2 hours in patients with normal renal function. In patients with severely impaired renal function (GFR <30 mL/min), half-life is significantly prolonged (up to 20 hours).
Renal excretion: 95% unchanged drug via glomerular filtration; biliary/fecal: <0.1%
Primarily renal excretion (glomerular filtration). >95% of the administered dose is eliminated unchanged in urine within 24 hours. Biliary/fecal elimination is negligible (<1%).
Category C
Category C
MRI Contrast Agent
MRI Contrast Agent